Must share post from "Tim" on YMB. Thank you to Dr. John

New Post Public Reply Private Reply Replies (5) Message Board
mtruong34
1,060
Must share post from "Tim" on YMB.

Thank you to Dr. John Bream and Dr Bruce Patterson who took some of their valuable time today to try to help my sister, who is in the ICU on mechanical ventilation with COVID and pneumonia at Citrus Memorial Hospital, Inverness, FL. Her situation is dire.
Friday will mark two weeks of hospitalization. The first week, she was given five rounds of Remdesivir (worthless) and convalescent plasma (worthless)...she digressed, got worse.
Now, much worse.
I have been trying desperately to get real help for my sister. A special thank you to Dr. Scott Kelly of Cytodyn. Here’s why. Last Saturday, I contacted Dr. Kelly. He immediately responded offering all help possible from Cytodyn, and asked me to have the attending physician(s) contact him directly to request Leronlimab via eIND. Cytodyn on board. Check.
Monday morning I was at hospital, not taking “no” for an answer and remaining there until I could speak directly to the doctors. That eventually happened. I requested, pleaded, begged for them to contact Dr. Kelly. After much emphatic pleading and citing Leronlimab’s tremendous safety and efficacy records, including some of the now well-known examples, they agreed to make the request. I gave them all of Dr. Kelly’s contact information. Upon contact, Cytodyn requested a current positive (or negative) COVID test. It was still positive - sent to Cytodyn. Check, help on its way.
Then nothing. Nothing. It has taken two whole subsequent days, but today I finally found out the hold up. Cytodyn on board, doctors on board. What is the hold up? “The hospital CMO and Administration has a ‘policy’ of not giving ‘unapproved, experimental’ medications to its patients.” I demanded to speak to the CMO and Administrator - more than once.
They sent the “quality control” and “safety” officers to meet privately with my brother-in-law and me this afternoon. During the conversation they cited, regarding the hospital’s “policy,” the oath of “to do no harm.” I explained harm can be done by omission as well as co-mission. I also strongly urged and pleaded 1. Compassionate use; 2. eIND; and 3. The right to try. (and 4. the dubious and regrettable record of the current standard of care). We offered to pay any uncovered costs, and offered to sign any waivers necessary to protect the hospital and doctors.
They are now addressing all the above within the hospital administration. And right now, tonight, my sister is lying in that room dying.
Tomorrow, we will be at it again (if she survives). Not going to stop. Please pray for my sister and all the others whose lives are currently being put in grave danger, and those who have died, because of institutional inaction and unjustifiable, harmful “policies.”

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 322

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 174

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 175

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 337

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 296

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 406

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 317

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 280

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 165

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

The Rise of Mycoplasma Testing: Future Growth and Trends

Updated Category News Views 102

Insights into the Growth of the Mycoplasma Testing Market The mycoplasma testing market is expected to balloon to USD 2.49 billion in the next few years. This impressive growth stems largely from the increasing use of cell culture techniques within biopharmaceutical research and development. As researchers and companies adopt these advanced methods, the demand for...

Continue Reading
Investors Urged to Examine Claims Against Toronto-Dominion Bank

Updated Category News Views 65

Faruqi & Faruqi Investigates Toronto-Dominion Bank Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating potential claims on behalf of investors who have suffered significant financial losses from their investments in The Toronto-Dominion Bank (NYSE: TD). The firm is reaching out to investors who experienced losses exceeding $100,000,...

Continue Reading
Heifer International Advocates for Farmer Support Amidst Crisis

Updated Category News Views 403

Heifer International Advocates for Farmer Support Amid Climate Crisis Heifer International is calling for urgent action to assist smallholder farmers affected by the extreme weather patterns brought on by climate change. The recent impact of Tropical Depression Sara highlights the vulnerability of agricultural communities across Central America, prompting the organization...

Continue Reading
Mitsubishi Tanabe Pharma Unveils RADICAVA ORS Insights at NASP

Updated Category News Views 135

Mitsubishi Tanabe Pharma America Unveils Data on RADICAVA ORS Mitsubishi Tanabe Pharma America, Inc. (MTPA) is thrilled to share vital information regarding their innovative product, RADICAVA ORS (edaravone), at an upcoming event designed for specialized pharmacy professionals. This presentation aims at enhancing the understanding of it’s application in managing...

Continue Reading
Warren Buffett's Coca-Cola Dividend Strategy: A Love Affair

Updated Category News Views 593

Warren Buffett's Love for Coca-Cola Warren Buffett, a legendary investor, is set to receive a staggering $776 million in dividends from Coca-Cola. This immense wealth from his investment in Coca-Cola illustrates the power of dividends in wealth accumulation. Buffett's investment journey with Coca-Cola has not only been fruitful financially but has also created a personal...

Continue Reading